Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
TNF regulates transcription of NLRP3 inflammasome components and inflammatory molecules in cryopyrinopathies
Matthew D. McGeough, … , Ariel E. Feldstein, Hal M. Hoffman
Matthew D. McGeough, … , Ariel E. Feldstein, Hal M. Hoffman
Published November 13, 2017
Citation Information: J Clin Invest. 2017;127(12):4488-4497. https://doi.org/10.1172/JCI90699.
View: Text | PDF
Research Article Immunology Inflammation

TNF regulates transcription of NLRP3 inflammasome components and inflammatory molecules in cryopyrinopathies

  • Text
  • PDF
Abstract

The NLRP3 inflammasome is a protein complex responsible for caspase-1–dependent maturation of the proinflammatory cytokines IL-1β and IL-18. Gain-of-function missense mutations in NLRP3 cause the disease spectrum known as the cryopyrin-associated periodic syndromes (CAPS). In this study, we generated Nlrp3-knockin mice on various KO backgrounds including Il1b/Il18-, caspase-1–, caspase-11– (Casp1/11-), and Tnf-deficient strains. The Nlrp3L351P Il1b–/– Il18–/– mutant mice survived and grew normally until adulthood and, at 6 months of age, exhibited marked splenomegaly and leukophilia. Injection of these mice with low-dose LPS resulted in elevated serum TNF levels compared with Nlrp3L351P Casp1/11–/– mice and Il1b–/– Il18–/– littermates. Treatment of Nlrp3A350V mice with the TNF inhibitor etanercept resulted in all pups surviving to adulthood, with normal body and spleen/body weight ratios. Nlrp3A350V Tnf–/– mice showed a similar phenotypic rescue, with marked reductions in serum IL-1β and IL-18, reduced myeloid inflammatory infiltrate in the skin and spleen, and substantial decreases in splenic mRNA expression of both inflammasome components (Nlrp3, Pycard, pro-Casp1) and pro-cytokines (Il1b, Il18). Likewise, we observed a reduction in the expression of both pro-Casp1 and pro-Il1b in cultured Nlrp3A350V Tnf–/– BM-derived DCs. Our data show that TNF is an important transcriptional regulator of NLRP3 inflammasome components in murine inflammasomopathies. Moreover, these results may have therapeutic implications for CAPS patients with partial responses to IL-1–targeted therapies.

Authors

Matthew D. McGeough, Alexander Wree, Maria E. Inzaugarat, Ariela Haimovich, Casey D. Johnson, Carla A. Peña, Raphaela Goldbach-Mansky, Lori Broderick, Ariel E. Feldstein, Hal M. Hoffman

×

Figure 4

TNF deficiency prevents and attenuates systemic inflammatory disease in Nlrp3A350V mice.

Options: View larger image (or click on image) Download as PowerPoint
TNF deficiency prevents and attenuates systemic inflammatory disease in ...
(A–C) Survival and growth of Nlrp3A350V, Nlrp3A350V Tnf–/–, and Nlrp3A350V Tnf+/– mice. Phenotypic comparison showing reduced survival and runting in Nlrp3A350V mice, with complete and partial rescue in Nlrp3A350V Tnf–/– and Nlrp3A350V Tnf+/– animals, respectively (n = 6 for Nlrp3A350V Tnf–/– mice, n = 10 for Nlrp3A350V Tnf+/– mice, and n = 18 for Nlrp3A350V mice). (D) The splenomegaly observed in Nlrp3A350V and Nlrp3A350V Tnf+/– mice was absent in Nlrp3A350V Tnf–/– mice (n = 5 mice/group). *P < 0.05 by Kruskal-Wallis with Dunn’s multiple comparisons test. Data represent the mean ± SEM. (E) Serum IL-1β levels were significantly reduced in Nlrp3A350V Tnf–/– mice compared with levels in Nlrp3A350V mice, with no difference detected in Nlrp3A350V Tnf+/– mice. (F) Nlrp3A350V Tnf–/– animals showed a significant reduction in serum IL-18 levels, while Nlrp3A350V Tnf+/– animals had an intermediate but significant reduction compared with levels in Nlrp3A350V mice. *P < 0.05, by unpaired, 2-tailed Student’s t test (E and F). Each data point represents an individual mouse; horizontal bars represent the mean.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts